跳至主要内容
临床试验/NCT02140749
NCT02140749已完成不适用

Randomized, Placebo-controlled Double-blind Cross-over Study to Evaluate the Effects of Short-chain Fructooligosaccharides on Stool Frequency in Constipated Subjects

NIZO Food Research2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2014年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
2
主要终点
Stool frequency (Number of complete bowel movements per day)

研究概览

简要总结

Rationale: The dietary short-chain fructooligosaccharides have been shown to increase fecal bacterial mass and fermentation metabolites which might stimulate gut motility. Therefore, these dietary non-digestible carbohydrates might relieve functional constipation.

Objective: Study the effect of short-chain fructooligosaccharides on functional constipation.

Study design: A 16-week, randomized, placebo-controlled, double-blind cross-over trial with intervention periods of 4 weeks with a run-in period of 4 weeks and a wash-out period of 4 weeks.

Study population: Human subjects with functional constipation according to ROMEIII criteria (total n=120; male and female; 18-75 yr).

Intervention: Placebo and one out of 3 dosages of short-chain fructo-oligosaccharides, (Degree of Polymerisation of 3-5; 2, 4 and 8 g/day) for 4 weeks. scFOS will be given as oral chews.

Main study parameters: The primary parameter is the number of complete bowel movements per day in subjects with functional constipation according to Rome III criteria. Secondary outcomes are Stool consistency (Bristol Stool Scale), Stool frequency, Severity of symptoms (Constipation Scoring System; CSS) and Quality of Life (Patient Assessment of Constipation Quality of Life; PAC-QoL).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-75 yr
  • Agree to study design (signed informed consent)
  • At least two of the following symptoms ≥25% of the time with criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to inclusion (ROME III criteria for functional constipation):
  • straining, lumpy or hard stool
  • sensation of incomplete evacuation
  • sensation of anorectal obstruction ⁄ blockage
  • use of manual manoeuvres
  • <3 bowel movements per week
  • Availability of internet connection
  • BMI 20-30
  • Male or female
  • Willingness to abstain from functional ingredients and such as probiotics, prebiotics and foods containing high amounts of fermentable fibers and laxatives starting 1 month prior to start of the study as well as during the washout period.

排除标准

  • Currently participating in another clinical trial
  • Drug usage
  • Excessive alcohol usage (>4 consumptions/day or >20 consumptions/week)
  • Pregnancy or lactating
  • Underlying disease of the GI-tract or previous laparotomy, except cholecystectomy and appendectomy
  • Use of antibiotics within 1 month prior to inclusion
  • Vegetarians
  • Weight loss > 5 kg within 1 month prior to inclusion

结局指标

主要结局

Stool frequency (Number of complete bowel movements per day)

时间窗: Change over week 4 and week 12

次要结局

  • Stool consistency (Bristol Stool Scale)(Change over week 4 and week 12)
  • Severity of symptoms (Constipation Scoring System; CSS)(Change over week 4 and week 12)
  • Quality of Life (Patient Assessment of Constipation Quality of Life; PAC-QoL)(Change over week 4 and week 12)

研究者

发起方
NIZO Food Research
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验